Hamyeh M, Bernex F, Larive R, Naldi A, Urbach S, Simony-Lafontaine J, Puech C, Bakhache W, Solassol J, Coopman P, Hendriks W, Freiss G PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness. 2020.
Mas S, Torro A, Bec N, Gongora C, Larroque C, Martineau P, de Juan A, Marco S MALDI imaging mass spectrometry and chemometric tools to discriminate highly similar colorectal cancer tissues. Talanta. 2020;208. doi:10.1016/j.talanta.2019.120455
Deshayes E, Fersing C, Meunier L, Guiu B Antiviral (Hepatitis C Virus) Drug-Drug Interaction Leading to Dramatic Underestimation of Liver Function With 99mTc-Mebrofenin Hepatobiliary Scintigraphy. Clin Nucl Med. 2020;45(2):133-135. doi:10.1097/RLU.0000000000002861
Hofman P, Dagher G, Laurent-Puig P, Hugo-Marquette C, Barlesi F, Bibeau F, Clément B [Tumor banks and complex data management: Current and future challenges]. Ann Pathol. Feb 25, 2019. doi:10.1016/j.annpat.2019.01.017
Latorzeff I, Bourgier C, Pinel B, Hennequin C, Jimenez G, Chapet O, Zasadny X [Treatment of primary disease (breast, non-small cell lung and prostate cancers) with irradiation in case of de novo metastatic cancer]. Cancer Radiother. Sep 06, 2019. doi:10.1016/j.canrad.2019.08.004
Bourgier C, Latorzeff I, Fenoglietto P, Boisselier P, Charissoux M, Llacer C, Lemanski C, Riou O, Farcy-Jacquet M-P, Azria D [Treatment of oligometastatic or oligoprogression cancer]. Cancer Radiother. Sep 05, 2019. doi:10.1016/j.canrad.2019.07.143
Poinas G, Blache J, Kassab-Chahmi D, Evrard P, Artus P, Alfonsi P, Beaussier M, Cerantola Y, Coloby P, Drapier É, Masson-Lecomt A, Le Normand L, Gamé X, Bosset P, Delaunay L, Fendler J, Ecoffey C, Cuvelier G [Short version of recommendations for enhanced recovery program (ERP) for cystectomy: Technical measures]. Prog. Urol.. 2019;29(2):63-75. doi:10.1016/j.purol.2018.12.002
Riou O, Bourgier C, Brengues M, Bonnefoi N, Michaud H-A, Castan F, Gourgou S, Draghici R, Farcy-Jacquet M-P, Bons F, Fenoglietto P, Ozsahin M, Azria D [Predictive assays for responses of tumors and normal tissues in radiation oncology]. Cancer Radiother. Aug 23, 2019. doi:10.1016/j.canrad.2019.07.152
Béganton B, Coyaud E, Mangé A, Solassol J [New approaches for protein-protein interaction study]. Med Sci (Paris). 2019;35(3):223-231. doi:10.1051/medsci/2019035
Pomel C, Lecuru F, Leblanc E, Mathevet P, Colombo P-E, Collinet P, Nadeau C, Huchon C, Chereau E, Lambaudie E, Ferry P, Rafii A, Rouzier R [Minimal invasive surgery for early stage cervical cancer. Recommendations from the GINECO surgeon's group]. Bull Cancer. Jul 25, 2019. doi:10.1016/j.bulcan.2019.05.010
[Management of patients with systemic treatments]. Prog. Urol.. 2019;29 Suppl 1. doi:10.1016/S1166-7087(19)30169-1
Riou O, Valdenaire S, Debuire P, Fenoglietto P, Debrigode C, Mazard T, Assenat É, Azria D [Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?]. Cancer Radiother. Aug 20, 2019. doi:10.1016/j.canrad.2019.07.159
Bourgier C, Lemanski C, Draghici R, Castan F, Fenoglietto P, Bons F, Farcy-Jacquet M-P, Brengues M, Gourgou S, Ozsahin M, Azria D [Individual modification of the dose, volume and fractionation of breast radiotherapy]. Cancer Radiother. Aug 01, 2019. doi:10.1016/j.canrad.2019.06.004
Pignot G, Houede N [Immunotherapy in urology: Concept and results]. Prog. Urol.. Aug 30, 2019. doi:10.1016/j.purol.2019.08.267
Pourquier P [Genetic and transcriptional evolution alters cancer cell line drug response]. Bull Cancer. 2019;106(1):9-10. doi:10.1016/j.bulcan.2018.12.002
Bakrin N, Classe J, Colombo P, Ferron G, Freyer G, Glehen O, Gouy S, Huchon C, Narducci F, Pocard M, Pomel C, Rouzier R [CHIP and ovarian cancer]. Gynecol Obstet Fertil Senol. Jun 26, 2019. doi:10.1016/j.gofs.2019.06.007
Houédé N, Milano G [Care of advanced or metastatic bladder cancer in second line: A specific place for vinflunine]. Bull Cancer. 2019;106(5):431-435. doi:10.1016/j.bulcan.2019.02.007
Bibeau F [Biomarker, what is the pathologist's role?]. Ann Pathol. 2019;39(3):177-178. doi:10.1016/j.annpat.2019.05.002
Badoual C, Bibeau F [Augmented pathology, future or present ?]. Ann Pathol. Mar 14, 2019. doi:10.1016/j.annpat.2019.02.009
Romanet P, Philibert P, Fina F, Cuny T, Roche C, Ouafik L, Paris F, Reynaud R, Barlier A Using Digital Droplet Polymerase Chain Reaction to Detect the Mosaic GNAS Mutations in Whole Blood DNA or Circulating Cell-Free DNA in Fibrous Dysplasia and McCune-Albright Syndrome. J. Pediatr.. 2019;205. doi:10.1016/j.jpeds.2018.09.070
Mas S, Torro A, Bec N, Erschov G, Gongora C, Larroque C, Martineau P, de Juan A, Marco S Use of physiological information based on grayscale images to improve mass spectrometry imaging data analysis from biological tissues. Anal. Chim. Acta. 2019;1074. doi:10.1016/j.aca.2019.04.074
Vendrell J, Senal R, Rouquette I, Quantin X, Pujol J-L, Bouidioua A, Godreuil S, Coyaud E, Brousset P Ultra-sensitive EGFRT790Mdetection as an independent prognostic marker for lung cancer patients harboring EGFRdel19mutations and treated with first-generation TKIs. Clin. Cancer Res.. Apr 01, 2019. doi:10.1158/1078-0432.CCR-18-2683
D'Hondt V, Canon J-L, Roca L, Levy C, Pierga J-Y, Le Du F, Campone M, Desmoulins I, Goncalves A, Debled M, Rios M, Ferrero J-M, Serin D, Hardy-Bessard A-C, Piot G, Brain E, Dohollou N, Orfeuvre H, Roché H, Delaloge S, Dalenc F UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2-positive subgroup. Eur. J. Cancer. 2019;122. doi:10.1016/j.ejca.2019.09.014
Quénet F, Pissas M-H, Gil H, Roca L, Carrère S, Sgarbura O, Rouanet P, de Forges H, Khellaf L, Deshayes E, Ychou M, Bibeau F Two-stage hepatectomy for colorectal liver metastases: Pathologic response to preoperative chemotherapy is associated with second-stage completion and longer survival. Surgery. 2019;165(4):703-711. doi:10.1016/j.surg.2018.10.006
Roux P, Knight S, Cohen M, Classe J, Mazouni C, Chauvet M-P, Reyal F, Colombo P-E, Jouve E, Chopin N, Daraï E, Coutant C, Lambaudie E, Houvenaeghel G Tubular and mucinous breast cancer: results of a cohort of 917 patients. 2019;105(1):55-62. doi:10.1177/0300891618811282
Institut de Recherche en Cancérologie de
